Jango to manage Grünenthal pain awards

February 3, 2011
Medical Communications Grunenthal, Jango, awards, disease awareness campaigns

Jango Communications has been appointed by Grünenthal to manage the Pain Awards Programme they are sponsoring this year. German-based Grünenthal, …

The Project Management Office – Accelerating Project Management Maturity

February 3, 2011
Sales and Marketing Kinapse, White paper

Success in the life sciences industry depends on allocation of scarce resource to the right projects at different stages of …

Diabetes success for Sanofi, disappointment for Roche

February 2, 2011
Roche, Sanofi, diabetes

The contrasting fortunes of two new diabetes became clear today, with Sanofi-Aventis lixisenatide performing well, as Roche abandoned taspoglutide.Sanofi’s lixisenatide, …

Sandwich R&D

Government seeks to salvage Pfizer site

February 2, 2011
Research and Development Pfizer, Sandwich

Science minister David Willetts says the government will do all it can to maintain pharma research in Kent, after Pfizer …

Leading universities sound alarm over UK research

February 2, 2011
Research and Development Jobs, Pfizer, Sandwich, universities

Cuts to government funding for research in universities have been condemned by the UK’s top centres of learning. The government …

cherry_wood

Cherry Wood new HCA chair

February 1, 2011
Medical Communications Cherry Wood, HCA

The Healthcare Communications Association (HCA) has announced that Cherry Wood, managing director of Liberation Communications, has been elected its new …

Pfizer's R&D site in Sandwich, Kent

Pfizer to close UK R&D site

February 1, 2011
Research and Development Kent, Pfizer, R&D, Sandwich, closure

Pfizer has announced that it is to close its UK research site at Sandwich in Kent, with the loss of …

GSK settles Avandia case out of court

February 1, 2011
Sales and Marketing Avandia, GSK, diabetes

GlaxoSmithKline this week settled a US federal lawsuit regarding its diabetes drug Avandia before it went to court. The company …

FDA process validation guidelines emphasise risk management

February 1, 2011
Manufacturing and Production FDA, ICH, process validation

The FDA has published the final version of its Guideline on Process Validation, more than two years after the first …

Sanofi – Genzyme deal edges closer

February 1, 2011
Sales and Marketing Genzyme, Lemtrada, Sanofi

Sanofi-Aventis has entered into a confidentiality agreement with Genzyme to discuss the prospects of Lemtrada, which suggests a deal could …

Oxford BioMedica buys decommissioned facility

February 1, 2011
Manufacturing and Production Oxford BioMedica, RecipharmCobra Biologics, manufacturing

Gene therapy specialist Oxford BioMedica has said it plans to acquire a £1.9 million ($3.1m) manufacturing facility from contract manufacturer …

Tarceva set for first line treatment

January 31, 2011
Sales and Marketing Iressa, NSCLC, Roche, Tarceva

Roche’s lung cancer treatment Tarceva has been shown to help patients as a first line treatment. An independent data monitoring …

UK hails high uptake of cervical cancer vaccine

January 31, 2011
Research and Development Cervarix, HPV

The NHS campaign to vaccinate girls against the future risk of developing cervical cancer has been a success, according to …

AstraZeneca revenues reach standstill

January 31, 2011
Sales and Marketing AstraZeneca, Full year 2010, patent expiry, results

AstraZeneca’s revenues came to a virtual standstill in 2010, with strong growth outside the US being offset by generic competition …

GSK and Actelion drop insomnia treatment

January 30, 2011
Research and Development Actelion, GSK, insomnia

Actelion and GlaxoSmithKline are to abandon development of phase III insomnia drug almorexant because of problems with side-effects.Almorexant a dual …

Mitsubishi Tanabe recalls two million injectables

January 28, 2011
Manufacturing and Production Mitsubishi, injectables, recall

Mitsubishi Tanabe Corp has said it will recall two million of its injectable medicines made at a facility in Ashikaga, …

Mike Paling receives outstanding contribution award

January 28, 2011
Medical Communications Mike Paling, TBWA/Paling Walters, awards

Mike Paling, chief executive and chairman of TBWA\Paling Walters has received an award for Outstanding Contribution to Pharmaceutical Marketing for …

EMA road map to prioritise pharmacovigilance

January 28, 2011
Research and Development, Sales and Marketing EMA, European Medicines Agency, pharmacovigilance

The European Medicines Agency is to prioritise issues such as pharmacovigilance over the next five years, while also looking closely …

Mixed picture on postcode prescribing

January 28, 2011
Sales and Marketing NHS reforms, PCTs, SHAs, postcode prescribing

There are high levels of variation between Strategic Health Authorities and Primacy Care Trusts in the uptake of new drugs, …

Decision on osteoporosis drug Protelos unchanged, says NICE

January 27, 2011
Sales and Marketing NICE, Protelos, Servier, osteoporotic fractures, strontium ranelate

NICE has published updated final guidance on preventing osteoporotic fractures following a reconsideration of the use of Servier’s Protelos. The …

The Gateway to Local Adoption Series

Latest content